Skip to content

    Tega Industries Q1 FY27 earnings call

    TEGA
    Capital Goods·13 Aug 2026
    Management Summary

    Tega Industries Limited reported a strong Q1 FY27, driven by robust performance in its legacy consumables business and the initial consolidation of Molycop's financials. Consolidated revenue reached INR17.2 billion with an adjusted EBITDA margin of 15%, despite significant one-time acquisition-related costs. The company maintains a healthy order book and is focused on integrating Molycop to unlock synergies and capitalize on favorable long-term market trends in copper and gold.

    Highlights

    5
    • Consolidated revenue from operations reached INR17.2 billion, reflecting strong growth and diversification benefits.

    • Adjusted EBITDA for the consolidated group stood at INR2.6 billion, with a healthy 15% margin.

    • Legacy Tega businesses delivered robust performance, with revenue growing 21% YoY to INR4.3 billion and EBITDA increasing 42% YoY to INR1 billion.

    • The consumables business, a key segment, saw revenue growth of 36% YoY to INR4 billion and EBITDA growth of 58% YoY to INR1 billion.

    • A healthy order book of INR12.3 billion provides strong revenue visibility, with INR9.6 billion executable within one year.

    Concerns

    2
    • One-time acquisition and integration expenses amounted to INR1.9 billion (consolidated) / INR1.95 billion (Molycop specific).

    • The equipment business experienced a 44% de-growth in revenue to INR0.36 billion, primarily due to delays in customer clearances.

    Key financials

    Single quarter

    05 metrics
    1. 01Consolidated Revenue17,200 Mn
    2. 02Consolidated Adjusted EBITDA2,600 Mn
    3. 03Consolidated Adjusted EBITDA Margin15%
    4. 04Legacy Tega Revenue Growth21%
    5. 05Legacy Tega EBITDA Growth42%

    Segment breakdown

    • Consumable Business (Legacy Tega)3,960 Mn23.0%
    • Equipment Business (Legacy Tega)360 Mn2.1%
    • Molycop (1 Month Contribution)12,900 Mn74.9%
    Donut· Share of Revenue

    Order Book

    high confidence

    Total Value

    ₹ 12,300 million

    as of 2026-06-30

    quantified

    Execution

    executable within one year

    "The healthy order book provides strong visibility for future revenue and reinforces confidence in the underlying demand environment."

    Source:
    Prepared remarks

    Capital allocation

    4
    high confidence
    CategoryHeadline
    Capex

    USD 40 million

    Debt

    Net ₹63,660 million

    M&A

    Molycop

    acquisition · integrated

    Liquidity

    Liquidity disclosed

    Deleveraging meaningfully strengthens our liquidity position and provides increased financial flexibility.

    Guidance & targets

    10
    CategoryTargetPriority
    Synergies
    Molycop integration synergies
    USD20 million
    High
    Market Growth
    Copper demand CAGR
    4.8%
    High
    Capacity
    Freeport Indonesia Grasberg full operating capacity
    full return
    High
    Volume Growth
    Molycop volume growth
    ~5%
    Medium
    EBITDA Growth
    Molycop EBITDA growth
    ~4%
    Medium
    Consumables Growth
    Consumables revenue CAGR
    15%
    High
    Profitability
    Consolidated EBITDA margin
    15%
    High
    Capex
    Tega (ex-Molycop) FY27 Capex
    USD40 million
    High
    Plant Commissioning
    Chile plant commercial production
    March 2027
    High
    Finance Cost
    Tega FY27 Finance Cost
    INR110-120 crores
    High

    What to watch in Q2 FY27

    5

    Cross-selling synergies quantification

    next couple of quarters
    CurrentEarly stages, no definitive numbers yet
    TargetMore definitive numbers on cross-selling opportunities and revenue ramp-up

    Why it matters

    Quantification of cross-selling synergies is key to understanding the full value creation potential of the Molycop acquisition.

    So, request a couple of quarters of patience with us and we'll be able to give you a more definitive number around it.

    Risks & concerns

    5
    RiskSeverity

    One-time acquisition and integration costs

    INR1.9 billion (consolidated) / INR1.95 billion (Molycop specific) incurred, but confirmed as fully accounted for in Q1.Management acknowledged

    medium

    Equipment business de-growth

    44% YoY de-growth due to delays in customer clearances, impacting short-term revenue.Management acknowledged

    medium

    Raw material price volatility

    Gross margins are protected through steel index-linked contracts and ability to pass through costs.Management acknowledged

    low

    Shipping related challenges and freight costs

    Logistics challenges exist, but costs are passed through to customers, and product delivery is maintained on time.Management acknowledged

    low

    Currency risks

    Molycop has a formal risk program to hedge FX exposure, historically not materially impacting EBITDA.Management acknowledged

    low

    Q&A highlights

    8

    “So, request a couple of quarters of patience with us and we'll be able to give you a more definitive number around it.”

    Analysts are keen on specific numbers for cross-selling, but management indicates it's too early to quantify, pushing back expectations for concrete figures.

    asked by Ankur Periwal

    3 min read7 chapters

    Detailed Narrative

    01

    Strong Q1 FY27 Performance Driven by Molycop Integration

    Tega Industries Limited delivered a robust Q1 FY27, with consolidated revenue from operations reaching INR17.2 billion and an adjusted EBITDA of INR2.6 billion, translating to a 15% margin. This performance includes one month of Molycop's contribution, which added INR12.9 billion in revenue and INR1.6 billion in EBITDA. The integration process, however, incurred INR1.9 billion in one-time📎 acquisition and integration expenses, with a provisional goodwill of INR50 billion recognized.

    02

    Robust Growth in Legacy Tega Businesses

    The legacy Tega businesses demonstrated strong underlying performance, with revenue growing 21% year-on-year to INR4.3 billion and EBITDA increasing 42% year-on-year to INR1 billion, improving the EBITDA margin to 22.1% from 19.1%. The consumables segment was a key driver, reporting INR4 billion in revenue, a 36% year-on-year increase, and a 58% rise in EBITDA to INR1 billion. Gross margins for legacy Tega businesses remained healthy at 62%.

    03

    Equipment Business Faces Short-Term Headwinds

    In contrast to the strong consumables performance, the equipment business experienced a softer quarter, with revenue declining 44% year-on-year to INR0.36 billion. This shortfall was primarily attributed to delays in customer clearances, impacting profitability due to lower volumes. Despite these near-term challenges, management remains confident in the long-term prospects of this business and is focused on strengthening its project pipeline and order conversion.

    04

    Significant Debt Reduction Post-Molycop Acquisition

    The company successfully deleveraged post-Molycop acquisition, with total net debt declining by INR32.18 billion (USD340 million) during the quarter. Molycop's net debt stood at INR63.66 billion (USD672.5 million) as of June 30, a significant reduction from INR95.8 billion (USD1.0 billion) at March 31. This deleveraging action has meaningfully strengthened the company's liquidity position and provided increased financial flexibility.

    05

    Strategic Focus on Synergies and Market Opportunities

    Tega aims to unlock USD20 million in synergies from the Molycop integration over the next 2-2.5 years, focusing on expense optimization, operational efficiency, and procurement. The company is well-positioned to capitalize on favorable industry fundamentals, with the global gold market expected to grow at a 2.2% CAGR through FY30 and copper demand projected to grow at a 4.8% CAGR. UNCTAD forecasts global copper demand to increase over 40% by 2040, driving demand for critical consumables.

    06

    Chile Plant Commissioning and Capex Plans

    The Chile plant is on track for a soft commissioning around January 2027, with commercial production anticipated by March 2027, subject to regulatory approvals. Molycop's capex for the 10-month period is estimated at USD28 million, with normalized capex for the next two years expected to be in the low to mid-USD30 million range. Tega's (excluding Molycop) FY27 capex is projected at approximately USD40 million, including the Chile project.

    07

    Robust Order Book and Margin Resilience

    The combined Consumable and Equipment segments maintain a healthy order book of INR12.3 billion, with INR9.6 billion executable within one year, providing strong visibility for future revenue. Despite raw material price volatility and shipping-related challenges, the company has successfully maintained strong gross margins (62% for legacy Tega, 36% for Molycop) by effectively passing through cost increases to customers, ensuring the consolidated EBITDA margin remains in the 15% range for the full year.

    This is an AI-generated summary of a publicly available earnings call transcript.